| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5509848 | Clinica Chimica Acta | 2016 | 8 Pages |
Abstract
Triggering receptor expressed on myeloid cells (TREMs) receptors constitute a family modulators in human innate immunity system that encode by a gene cluster. Rare variants in TREM2 were reported to be associated with significant Alzheimer's disease (AD) risk. However, inconsistent results were also reported in some studies of Non-European descents. Recently, the other TREM family members are also considered to involve in AD and cerebrospinal fluid (CSF) soluble form of TREM2 (sTREM2) levels has also been associated with respond to progression of disease. In this review, we converged the data of genetic and clinical investigations to identify the clearer role of TREMs in AD. Here, comprehensively analyze of multidisciplinary fields highlights the contribution of TREMs locus to AD development.
Keywords
NHDTREM2SNPsGSK3βHDLNFTscdk5MMSEFTDAβMCLP-Tauamyloid β-proteinApoeapolipoprotein Eapolipoprotein Jmild cognitive impairmentEpigeneticAlzheimer's diseaseALSParkinson's diseaseBiomarkerHyperphosphorylated taucyclin-dependent kinase 5frontotemporal dementiaTREMlow density lipoproteinLDLhigh density lipoproteinsCerebrospinal fluidCSFGenome-wide association studiesGWASMini-Mental State ExaminationApoJneurofibrillary tanglesSingle nucleotide polymorphismstriggering receptor expressed on myeloid cells
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Jia Cheng, XiaoFeng Guo, Tian Zhang, Li Zhong, GuoJun Bu, XiaoFen Chen,